Shorook Naara

11PUBLICATIONS
73CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsOtorhinolaryngologyPhylogeny and comparative analysisSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 03, 2026
Psilocybin prevents chemotherapy-induced peripheral neuropathy through mitochondrial trafficking preservation.

|May 25, 2026
Potent Anti-Tumor Activity of the AXL-Targeted Antibody-Drug Conjugate, Mipasetamab Uzoptirine (ADCT-601), in Preclinical Models of Adenoid Cystic Carcinoma.

|May 05, 2026
Potent anti-tumor activity of the AXL-targeted antibody-drug conjugate, mipasetamab uzoptirine (ADCT-601), in preclinical models of adenoid cystic carcinoma.

|Apr 14, 2025
Evaluation and Outcomes of Iatrogenic Oropharyngeal Dysphagia.

Shorook Naara, Shadi Shinnawi, Nadeem Habashi

|Feb 20, 2025
Blockade of the PGE2 Pathway Inhibits the Growth of PTEN-Deficient HNSCC Tumors.

Jacqueline P Nguyen, Shorook Na'ara, Liam C Woerner

|Jan 22, 2025
Multi-Institutional Comparison of Quality of Life Between Open Versus Endoscopic Skull Base Approaches.

John R de Almeida, Katrina Hueniken, Michael Xie

Pageof 2

Frequent Collaborators

2 joint publications

Moran Amit

2 joint publications

Hyunseok Kang

2 joint publications

Anita Pothukuchi

2 joint publications

Leilani Jones